The ability of BDNF in the NAc an VTA in to regulate mood & motivational

NAc 和 VTA 中的 BDNF 调节情绪的能力

基本信息

项目摘要

Project 2 focuses on the ability of BDNF (brain-derived neurotrophic factor) in the NAc (nucleus accumbens) and VTA (ventral tegmental area) to regulate mood and motivational state. Most work in the field (including considerable work by Center investigators) has focused on an antidepressant-like influence of BDNF in hippocampus or frontal cortex. While we continue to analyze the importance of these findings (via other grants), we have provided novel evidence for a very different role played by BDNF and its signaling cascades acting at the level of the VTA-NAc circuit. This work has taken advantage of new tools, developed in conjunction with the Transgenic Core, which enable the selective knockout of BDNF signaling in the VTA, NAc, or other brain regions. This research has revealed that, in the VTA-NAc reward circuit, BDNF mediates a pro-depressant-like effect, with loss of BDNF selectively in this circuit mediating an antidepressant-like effect, in several animal models in both rats and mice. The goal of the proposed studies is to further establish the role played by BDNF in the VTA-NAc as it relates to mood, motivation, and depression, and to begin to identify the molecular substrates through which BDNF produces these novel effects. For example, recent findings from DNA expression arrays and behavioral studies have implicated several specific BDNF signaling proteins (in particular, the PI-3-kinase/Akt cascade) as key mediators of the BDNF behavioral phenotype in the VTA-NAc. We are now systemically analyzing the influence of these signaling proteins in animal models of depression and antidepressant action. We have also established BDNF and certain of its signaling proteins as key regulators of the morphology of VTA and NAc neurons, which we have demonstrated is altered by chronic exposure to stress, and we are interested in relating these findings to behavior. A relationship between BDNF and CREB is another focus of Project 2. We hypothesize that regulation of CREB activity is a major functional output of BDNF signaling in the VTA- NAc pathway. Conversely, we have growing evidence that CREB in turn regulates the VTA-NAc circuit in part via its control of BDNF gene expression. We are now using the unique molecular tools available to this Center to explore these possibilities as well as their detailed underlying molecular mechanisms.
项目2的重点是BDNF(脑源性神经营养因子)在NAc(脑桥核)中的能力 腹侧被盖区(ventral tegmental area,VTA)调节情绪和动机状态。大多数在外地工作(包括 中心研究人员的大量工作)集中在BDNF在脑内的抗抑郁样影响上。 海马体或额叶皮层。虽然我们继续分析这些发现的重要性(通过其他 我们为BDNF及其信号传导所起的非常不同的作用提供了新的证据 级联作用于VTA-NAc电路的水平。这项工作利用了新的工具, 与能够选择性敲除VTA中BDNF信号传导的转基因核心结合, NAc或其他大脑区域。这项研究表明,在VTA-NAc奖励回路中,BDNF介导了 一种类似促抑郁症的效应,在这个回路中选择性地失去BDNF,介导一种类似抗抑郁症的效应。 在大鼠和小鼠的几种动物模型中, 这项研究的目的是进一步确定BDNF在VTA-NAc中的作用, 情绪、动机和抑郁,并开始识别脑源性神经营养因子通过的分子底物 产生了这些新奇的效果。例如,最近从DNA表达阵列和行为分析中发现, 研究已经涉及几种特定的BDNF信号传导蛋白(特别是PI-3-激酶/Akt级联) 作为VTA-NAc中BDNF行为表型的关键介质。我们现在正在系统地分析 这些信号蛋白在抑郁症和抗抑郁作用的动物模型中的影响。我们有 还确立了BDNF及其某些信号蛋白作为VTA形态的关键调节因子, NAc神经元,我们已经证明了慢性暴露于压力会改变,我们感兴趣的是 将这些发现与行为联系起来。BDNF和CREB之间的关系是项目2的另一个焦点。 我们假设CREB活性的调节是VTA中BDNF信号传导的主要功能输出, NAc途径。相反,我们有越来越多的证据表明CREB反过来调节VTA-NAc回路, 部分通过其对BDNF基因表达的调控。我们现在正在使用独特的分子工具, 中心探索这些可能性以及它们详细的潜在分子机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Luis Fernando Parada其他文献

Luis Fernando Parada的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Luis Fernando Parada', 18)}}的其他基金

Isolation, characterization and translational development of glioma stem cells
神经胶质瘤干细胞的分离、表征和转化发育
  • 批准号:
    10555234
  • 财政年份:
    2017
  • 资助金额:
    $ 16.67万
  • 项目类别:
Isolation, characterization and translational development of glioma stem cells
神经胶质瘤干细胞的分离、表征和转化发育
  • 批准号:
    10337037
  • 财政年份:
    2017
  • 资助金额:
    $ 16.67万
  • 项目类别:
Isolation, characterization and translational development of glioma stem cells
神经胶质瘤干细胞的分离、表征和转化发育
  • 批准号:
    10090574
  • 财政年份:
    2017
  • 资助金额:
    $ 16.67万
  • 项目类别:
PROJECT 2: NF1-associated Glioblastoma
项目 2:NF1 相关胶质母细胞瘤
  • 批准号:
    10494106
  • 财政年份:
    2015
  • 资助金额:
    $ 16.67万
  • 项目类别:
PROJECT 2: NF1-associated Glioblastoma
项目 2:NF1 相关胶质母细胞瘤
  • 批准号:
    10270582
  • 财政年份:
    2015
  • 资助金额:
    $ 16.67万
  • 项目类别:
Genetic Mouse Models of Glioma
神经胶质瘤的遗传小鼠模型
  • 批准号:
    8010613
  • 财政年份:
    2009
  • 资助金额:
    $ 16.67万
  • 项目类别:
Genetic Mouse Models of Glioma
神经胶质瘤的遗传小鼠模型
  • 批准号:
    8215765
  • 财政年份:
    2009
  • 资助金额:
    $ 16.67万
  • 项目类别:
Genetic Mouse Models of Glioma
神经胶质瘤的遗传小鼠模型
  • 批准号:
    7655161
  • 财政年份:
    2009
  • 资助金额:
    $ 16.67万
  • 项目类别:
Genetic Mouse Models of Glioma
神经胶质瘤的遗传小鼠模型
  • 批准号:
    7756644
  • 财政年份:
    2009
  • 资助金额:
    $ 16.67万
  • 项目类别:
Genetic Mouse Models of Glioma
神经胶质瘤的遗传小鼠模型
  • 批准号:
    8839207
  • 财政年份:
    2009
  • 资助金额:
    $ 16.67万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 16.67万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 16.67万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 16.67万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 16.67万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 16.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 16.67万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 16.67万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 16.67万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 16.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 16.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了